The development of strategies to enhance the survival of transplanted organs and to potentially lower or even discontinue immunosuppressive therapy would represent a significant advancement in post-transplant patient care.
Department of Immunology and Clinics of Organ Transplantation, Ospedali Riuniti Bergamo--Mario Negri Institute for Pharmacological Research, Bergamo, Italy. noris@irfmn.mnegri.it
